These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 15477707)
21. Pulmonary neuroendocrine/carcinoid tumors: a review article. Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772 [TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and surgical management in gastrointestinal neuroendocrine tumors]. Tomulescu V; Stănciulea O; Dima S; Herlea V; Stoica Mustafa E; Dumitraşcu T; Pechianu C; Popescu I Chirurgia (Bucur); 2011; 106(2):151-61. PubMed ID: 21698857 [TBL] [Abstract][Full Text] [Related]
23. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Strosberg J; Nasir A; Coppola D; Wick M; Kvols L Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957 [TBL] [Abstract][Full Text] [Related]
24. Endocrine tumours of the hindgut. Vogelsang H; Siewert JR Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):739-51. PubMed ID: 16253898 [TBL] [Abstract][Full Text] [Related]
25. [Definition and histologic characterization of neuroendocrine tumors]. Saint-André JP; Valo I; Guyétant S Rev Prat; 2002 Feb; 52(3):250-5. PubMed ID: 11925713 [TBL] [Abstract][Full Text] [Related]
26. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765 [TBL] [Abstract][Full Text] [Related]
27. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283 [TBL] [Abstract][Full Text] [Related]
28. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M; Acta Oncol; 2004; 43(7):626-36. PubMed ID: 15545183 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract]. Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675 [TBL] [Abstract][Full Text] [Related]
30. [Neuroendocrine tumours of the gastrointestinal tract]. Plöckinger U; Wiedenmann B Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448 [TBL] [Abstract][Full Text] [Related]
31. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625 [TBL] [Abstract][Full Text] [Related]
32. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Ardill JE; O'Dorisio TM Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M; Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182 [TBL] [Abstract][Full Text] [Related]
34. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Quaedvlieg PF; Visser O; Lamers CB; Janssen-Heijen ML; Taal BG Ann Oncol; 2001 Sep; 12(9):1295-300. PubMed ID: 11697843 [TBL] [Abstract][Full Text] [Related]
36. The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. Lim E; Yap YK; De Stavola BL; Nicholson AG; Goldstraw P J Thorac Cardiovasc Surg; 2005 Oct; 130(4):969-72. PubMed ID: 16214506 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345 [TBL] [Abstract][Full Text] [Related]
38. Comment on Ramage et al.: Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology 2008;87:31-39. Scherübl H Neuroendocrinology; 2008; 88(3):157-8; author reply 158-9. PubMed ID: 18849621 [No Abstract] [Full Text] [Related]
39. [Neuroendocrine tumors of the lung]. Oliaro A; Donati G; Filosso PL; Ruffini E Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278 [TBL] [Abstract][Full Text] [Related]
40. [New approaches to early detection, estimation of prognosis and therapy for malignant tumours of the gastrointestinal tract]. Röcken C; Neumann U; Ebert MP Z Gastroenterol; 2008 Feb; 46(2):216-22. PubMed ID: 18253902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]